Home » Topics » BioWorld Science

BioWorld Science
RSS

RCC-33 reduces tumor volume in mice inoculated with colorectal cancer cells

Feb. 4, 2021

Phase Ib data show lack of objective response for CMP-001 plus atezolizumab in NSCLC

Feb. 4, 2021

California Institute of Technology, Rockefeller University describe anti-HIV vaccine antibodies

Feb. 4, 2021

Novartis discovers AKR1C3-dependent GTPase KRAS inhibitors

Feb. 4, 2021

Cybrexa 3 patents peptide conjugates of microtubule-targeting agents

Feb. 4, 2021

New cannabinoid CB1 and CB2 receptor ligands identified at Canopy Growth Corp.

Feb. 4, 2021

Preliminary phase I data show safety and immunogenicity of VXA-CoV2-1 oral tablet vaccine

Feb. 4, 2021

Positive topline data from phase II study of Allocetra in severe and critical COVID-19

Feb. 4, 2021

Crinetics initiates phase I study of CRN-04777

Feb. 4, 2021

Multivalent nanobodies potently neutralize SARS-CoV-2 and prevent mutational escape

Feb. 4, 2021

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...